Patient: Page 18
-
PharmaVoice Team/PharmaVoice
Upfront
Pfizer Service Provides Social Workers for Patients Pfizer Oncology Together is a first-of-its-kind offering for patients taking Pfizer Oncology medicines. The program offers dedicated social workers called “Care Champions" to help navigate the complexities that accompany treatment, such as ident...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
HealthTech
LivaNova Receives FDA Approvals for SenTiva Device for Treatment of Epilepsy Trend Watch: Health Technology Increases Wellness Across Epilepsy, Autism, and Weight Loss LivaNova, a market-leading medical technology company, has received FDA approval for its latest vagus nerve stimulation therapy (...
By PharmaVoice Team • Nov. 20, 2017 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Last Word
Digital Health Initiatives Georgia Mitsi, Senior Director, Search Evaluation & Digital Health Care Initiatives, at Sunovion Pharmaceuticals, discusses the company’s digital health efforts. PV: What is the driving force behind the many digital health initiatives at Sunovion? Mitsi: Sunovion’s ...
By Georgia Mitsi • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: What Does the Future Hold?
We tasked the PharmaVOICE 100 community of industry executives to think about some of the most important trends they expect will challenge the status quo, move the industry forward, and contribute to breakthroughs in medicine and business models. Their thoughtful insights signal the multitude of ...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Pipeline Disrupters
In recent years, several therapeutic disruptors have hit the market, pushing aside current standard treatment protocols. From hepatitis C cures to immuno-oncology therapies, recent approvals have upended how diseases are treated, providing patients with significant advances. Pharmaceutical, biote...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Treatment to Wellness
Attitudes about treating disease are undergoing a fundamental shift as the life-sciences industry faces pressure to demonstrate value. Increasingly, there is a move from treatment to prevention, diagnostics and cure, which KPMG says is leading to the rise of new competitors. By 2030, practitioner...
By Kim Ribbink • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Red Zone: Healing Patients With Digital Warmth: A Prescription for Life Sciences
Earlier this year, ReD Associates and Cognizant conducted an extensive research that cut across disease areas to understand how patients heal – that is, what happens when people face a health risk or issue and need to manage or overcome it. By participating in people’s everyday lives, we found th...
By Bhaskar Sambasivan • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Red Zone: safety portal: Increasing Patient Safety While Reducing Cost and Complexity
Although it sounds straightforward, global safety reporting of clinical trial adverse events is complicated, time-consuming and extremely expensive. Despite the substantial investment of time and money, research shows that global safety reporting is not protecting patients as well as it could. Dr...
By Steven Beales • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Patient Solutions: Responding to the Needs of the Savvy Patient
Responding to the Needs of the Savvy Patient When healthcare IT strategist Leonard Kish referred to patient engagement as the blockbuster drug of the century, he tapped into an important realization: that the patient has to be at the center of everything a pharmaceutical company does. Today’s pat...
By PharmaVoice Team • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
A Roadmap for Patient-Centric Patient Support Programs
Patient-centricity is widely embedded into the mission statements and values of biopharma organizations. It gives purpose and urgency to efforts across research, development, and commercialization. Yet patient-centricity often is vaguely defined — making the goal hard to achieve. Teams striving f...
By Lauren Walrath • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
Precision Medicine Meets Precision Patient Support
In the value-driven healthcare environment, orphan drug manufacturers are becoming increasingly aware that improving adherence requires a new approach to patient understanding and support. Take for example the required lifestyle, nutritional or physical modifications often necessary for patient c...
By Kathi Henson • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
Impact Patient Outcomes Without Talking to the Patient
Patient marketers are used to providing valuable patient services and information directly to patients. But if the goal is to accelerate patient outcomes, the needs of the caregiver should also be addressed. Patient marketers know that caregivers play an important part in patients’ lives, but the...
By Andi Weiss • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Connected Consumer
At some point during the far-off days of the Carter administration, Carnegie Mellon expanded its Computer Science department, leaving programmers farther away from the department’s only Coke machine. So rather than trek down a couple of floors only to find an empty vending machine, or worse, a ma...
By Johanna Skilling • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Patients as people The term patient-centricity has been used so frequently — including in the pages of PharmaVOICE — that it has almost begun to lose meaning … almost. Patient empowerment began to erode the traditional power center of medicine — the doctor — with the first direct-to-consumer adve...
By Taren Grom • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Future of Patient-Focused Marketing from the Agency C-Suite
Marketers in the life-sciences field are facing ever-evolving challenges to meet ever-changing patient expectations. According to one recent study, 77% of patients start their health journey online beginning at a search engine. This action alone provides marketers huge opportunities as well as ch...
By PharmaVoice Team • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
Patient-Centered Trials
Researchers, physicians, pharma, and biotech developers all want to do the right thing for patients. Everyone in the industry understands the need to develop transformative therapies for those with disease. But historically, patients have often been invisible. Although patients are the ultimate c...
By PharmaVoice Team • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
Nikki Levy Caring Connections Title: VP, Patient Engagement Company: Alkermes Inc. Education: BS, Communications, Illinois State University Family: As a child of a single mom she learned to be fiercely independent, internally motivated and to value hard work Hobbies: Running, reading, traveling A...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
Last Word
Bringing Patients’ Voices to Drug Development Sudip Parikh, Senior VP and Managing Director of DIA Americas, talks about the Drug Information Association’s survey of patient-centric initiatives in drug development. PV: What are the notable findings fromDIA’s survey about patient-centricity in dr...
By Sudip Parikh • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Improved Patient-Centricity Means Improved Patient Diversity Too
Increasing the diversity of patients enrolled in clinical trials of new medicines has become a growing theme for improving the clinical trial process. There is broad recognition that research participants need to be representative of the patient population who will ultimately use the product. Res...
By Scott Gray • June 1, 2017 -
PharmaVoice Team/PharmaVoice
eConsent: Reducing Uncertainty to Retain Patients
Imagine you’re applying for a new bank account. A bank associate guides you through forms, pointing at where your signature belongs. He’s got good intentions and wants to help, but speaks quickly with jargon and acronyms. You leave feeling cautiously optimistic, as you still have questions. Weeks...
By Eric Delente • June 1, 2017 -
PharmaVoice Team/PharmaVoice
HBA Rising Stars & Luminaries: A Vision of the Future
PharmaVOICE asked the nearly 100 industry executives identified by their companies as HBA Rising Stars and Luminaries to identify the biggest trends they believe will impact the industry in the next few years. Top on their lists are innovation and value. They also tackle the topics of big data, p...
By PharmaVoice Team • May 1, 2017 -
PharmaVoice Team/PharmaVoice
Rare Recruitment
Efforts to bring treatments to market for the approximately 7,000 rare diseases affecting more than 350 million people globally have been stepped up in recent years. But in order to bring products to market, companies must conduct clinical trials with a large enough patient population — relative ...
By Kim Ribbink • May 1, 2017 -
PharmaVoice Team/PharmaVoice
Patient Stories
As the industry continues to embrace a more patient-centric business model, patient views have shifted to the forefront of several strategies, including using patient advisory boards for drug development and clinical trial protocols, and patient stories and communities to guide marketing and othe...
By Robin Robinson • March 1, 2017 -
PharmaVoice Team/PharmaVoice
Partnering for More Impactful Patient Recruitment Services
Sponsors of global clinical trials increasingly need a strategic partner for their patient enrollment challenges, as opposed to enlisting an array of outsourced tactical vendors through a standard RFP process. Why have such partnerships become critical for on-time trial completion? There are a nu...
By Elaina N. Haeuber • Feb. 1, 2017 -
PharmaVoice Team/PharmaVoice
mHealth
Remote Patient Monitoring Device Market to Reach $1.5 Billion by 2024 Trending Now: From smart bras to inhalers, remote monitoring devices continue to gain traction. Cardiovascular Diseases, Respiratory Disorders, and Diabetes Drive Growth in Global Remote Patient Monitoring Device Market Accord...
By PharmaVoice Team • Nov. 21, 2016
Previous
